Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Lymphoid × duvelisib × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1 Lymphoma, Non-Hodgkin 1 Leukemia, Lymphoid 1 Hodgkin Disease 1

Interventions

fludarabine 3 Busulfan 3 thymoglobulin 2 fludarabine phosphate 2 Behavior Therapy 2 romiplostim 1 duvelisib 1 Social Determinants of Health 1 Methotrexate 1 Melphalan 1 Dasatinib 1 Azacitidine 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05065866 2025-12-04

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡